Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer

NCT01897454 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Study was terminated due to slower than anticipated accrual

Conditions

Pancreatic Adenocarcinoma
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Stage III Pancreatic Cancer

Interventions

DRUG: Fluorouracil
DRUG: Gemcitabine Hydrochloride
RADIATION: Intensity-Modulated Radiation Therapy
DRUG: Irinotecan Hydrochloride
DRUG: Leucovorin Calcium
DRUG: Oxaliplatin

Sponsor

Albert Einstein College of Medicine

Collaborators

[object Object]